Gilead, Teva Document Disclosures Helped Sway Jury In Rare Pay-For-Delay Trial

 
• By Brenda Sandburg
  
HIV gavel
A jury found the Gilead-Teva HIV drug patent settlement agreement was not anticompetitive. • Source: Shutterstock

More from Legal & IP

More from Pink Sheet